A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
The principal excitatory neurotransmitter in the vertebrate central nervous system, L-glutamate, acts on three classes of ionotripic glutamate receptors, named after the agonists AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxalole-4-propionic acid), NMDA (N-methyl-D-aspartate) and kainate. The development of selective pharmacological agents has led to a detailed understanding of the physiological and pathological roles of AMPA and NMDA receptors. In contrast, the lack of selective kainate receptor ligands has greatly hindered progress in understanding the roles of kainate receptors. Here we describe the effects of a potent and selective agonist, ATPA ((RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid) and a selective antagonist, LY294486 ((3SR, 4aRS, 6SR, 8aRS)-6-((((1H-tetrazol-5-yl) methyl)oxy)methyl)-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylic acid), of the GluR5 subtype of kainate receptor. We have used these agents to show that kainate receptors, comprised of or containing GluR5 subunits, regulate synaptic inhibition in the hippocampus, an action that could contribute to the epileptogenic effects of kainate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In hippocampus, exogenous kainate reduces the amplitude and Pr of evoked IPSCs onto CA1 pyramidal cells (208, 231, 734, 951) (however cf. with Refs. 231, 332).”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [208]
Citations
Cites
Hollmann, M., & Heinemann, S. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.000335 · Cited by 3,975
Molecular diversity of glutamate receptors and implications for brain function
Nakanishi, S. (1992) · Science · doi:10.1126/science.1329206 · Cited by 2,543
Excitatory Amino Acid Transmitters
Watkins, J. C., & Evans, R. H. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.001121 · Cited by 2,491 · cited 1×
“gif" NDATA ITEM> ]> The principal excitatory neurotransmitter in the vertebrate central nervous system, L -glutamate, acts on three classes of ionotripic glutamate receptors, named after the agonists AMPA (α-amino-3-hydroxy-5-methyl-4-isoxalole-4-propionic acid), NMDA ( N -methyl- D -aspartate) and kainat”
BackgroundMonaghan, D. T., Bridges, R. J., & Cotman, C. W. (1989) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.29.040189.002053 · Cited by 2,194
Excitatory amino acid receptors in the vertebrate central nervous system.
Collingridge, G. L., & Lester, R. A. (1989) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00025-0 · Cited by 1,341
Self-citationBettler, B., Boulter, J., Hermans-Borgmeyer, I., O'Shea-Greenfield, A., Deneris, E. S., Moll, C., Borgmeyer, U., Hollmann, M., & Heinemann, S. (1990) · Neuron · doi:10.1016/0896-6273(90)90213-y · Cited by 649 · cited 1×
“Here we describe the effects of a potent and selective agonist, ATPA (( RS )-2-amino-3-(3-hydroxy-5- tert -butylisoxazol-4-yl)propanoic acid) and a selective antagonist, LY294486 ((3SR, 4aRS, 6SR, 8aRS)-6-((((1H-tetrazol-5-yl) methyl)oxy)methyl)-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylic acid),…”
BackgroundPartin, K. M., Patneau, D. K., Winters, C. A., Mayer, M. L., & Buonanno, A. (1993) · Neuron · doi:10.1016/0896-6273(93)90220-l · Cited by 583
Bettler, B., & Mulle, C. (1995) · Neuropharmacology · doi:10.1016/0028-3908(94)00141-e · Cited by 456
Huettner, J. E. (1990) · Neuron · doi:10.1016/0896-6273(90)90163-a · Cited by 420 · cited 1×
“Currents activated by kainate in acutely isolated dorsal root ganglion (DRG) neurons are thought to be mediated by GluR5 receptor”
BackgroundRegulation of glutamate release by presynaptic kainate receptors in the hippocampus
Chittajallu, R., Vignes, M., Dev, K. K., Barnes, J. M., Collingridge, G. L., & Henley, J. M. (1996) · Nature · doi:10.1038/379078a0 · Cited by 394 · cited 1×
“GYKI53655 (LY300168) was used to eliminate AMPA receptor-mediated synaptic transmission while preserving functional kainate receptor”
MethodSelf-citation
Research works printed but not linked: 2
- Seeburg, P. H. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 14, 297–303 (1993).
- Bleakman, D. et al. Pharmacological discrimination of GluR5 and GluR6 kainate receptor subtypes by (3 S, 4a R, 6 R, 8a R)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3 carboxylic-acid. Mol. Pharmacol. 49, 581–585 (1996).
Cited by
Items 301–400 of 427
Mayer, M. L. (1997) · Nature · doi:10.1038/39177 · Cited by 15
Kainate receptor regulation of synaptic inhibition in the hippocampus
Pressey, J. C., & Woodin, M. A. (2020) · The Journal of Physiology · doi:10.1113/jp279645 · Cited by 15
“Pharmacological activation of presynaptic KARs can reduce GABA release probability and depress inhibition in the CA1 region (Clarke et al. 1997; Rodrı́guez-Moreno et al. 1997).”
BackgroundIreland, M. F., Lenal, F., Lorier, A. R., Loomes, D., Adachi, T., Alvares, T. S., Greer, J. J., & Funk, G. D. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.150532 · Cited by 14
“Journal compilation C© 2008 The Physiological Society ATPA is more than 100-fold more selective for GluR5-containing KA receptors than other KA and AMPA receptors (Clarke et al. 1997), but the EC50 for ATPA at these other receptors is only 3- to 4-fold higher than used here.”
BackgroundMethodResultInfluentialPsychotropic and neurotropic activity1
Vogel, H. G., Vogel, W. H., Schölkens, B. A., Sandow, J., Müller, G. A., & Vogel, W. F. (2002) · Springer eBooks · doi:10.1007/3-540-29837-1_6 · Cited by 14
Metabotropic signaling by kainate receptors
Rodrigues, R. J., & Lerma, J. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.35 · Cited by 19
Stimulation of lateral hypothalamic kainate receptors selectively elicits feeding behavior
Hettes, S. R., Heyming, T. W., & Stanley, B. G. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.060 · Cited by 14
“For example, evidence suggests that while KARs are localized both pre- and postsynaptically, AMPARs appear to be located primarily within the postsynaptic density of glutamatergic synapses (for review, see Chittajallu et al., 1999; Frerking and Nicoll, 2000; Patneau et al., 1993; Pinheiro and Mulle, 2006).”
BackgroundMethodInfluentialMelyan, Z., & Wheal, H. V. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9557-5_5 · Cited by 13
Miyata, M., & Imoto, K. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164996 · Cited by 14
“To examine this hypothesis, we bath-applied ATPA, a GluR5 agonist (Clarke et al. 1997), and then observed NMDAR-mediated EPSCs in CT–TC and CT–RT synapses.”
MethodActivation of Group I Metabotropic Glutamate Receptors Potentiates Heteromeric Kainate Receptors
Rojas, A., Wetherington, J. P., Shaw, R. N., Serrano, G. E., Swanger, S. A., & Dingledine, R. J. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.081802 · Cited by 16
“…root ganglia, where they are located on both presynaptic and postsynaptic terminals and mediate synaptic transmission and synaptic plasticity (Chittajallu et al., 1996, Clarke et al., 1997, Rodriguez-Moreno et al., 1997, Bortolotto et al., 1999a, Lerma et al., 2001, Huettner, 2003, Lerma, 2003).”
Bunch, L., Gefflaut, T., Alaux, S., Sagot, E., Nielsen, B., & Pickering, D. S. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.011 · Cited by 13
Vitten, H., Reusch, M., Friauf, E., & Löhrke, S. (2004) · Journal of Neurobiology · doi:10.1002/neu.10326 · Cited by 14
“The mean peak amplitude of the ATPA-evoked currents was 51 20 pA [Fig.”
BackgroundMethodInfluentialKang, N., Jiang, L., He, W. J., Xu, J., Nedergaard, M., & Kang, J. (2004) · Journal of Neurophysiology · doi:10.1152/jn.01231.2003 · Cited by 13
Xu, C., Cui, C., & Alkon, D. L. (2009) · Hippocampus · doi:10.1002/hipo.20544 · Cited by 13
“sIPSC, a GluR5 selective agonist, ATPA (Clarke et al., 1997; Clarke and Collingridge, 2002), was tested.”
MethodPotentiation of tonic GABAergic inhibition by activation of postsynaptic kainate receptors
Jiang, L., Kang, D.-S., & Kang, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.043 · Cited by 15
Haumann, I., Junghans, D., Anstötz, M., & Frotscher, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172967 · Cited by 13
More, J. C. A., Troop, H. M., & Jane, D. E. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704957 · Cited by 13
“These antagonists have been used to demonstrate that GluR5-containing kainate receptors are involved in the control of transmitter release (Clarke et al., 1997; Chittajallu et al., 1999) and in nociceptive signalling (Simmons et al., 1998).”
BackgroundInfluentialSPECT tracer [123I]IBZM has similar affinity to dopamine D2 and D3 receptors
Videb�k, C., Toska, K., Scheideler, M. A., Paulson, O. B., & Knudsen, G. M. (2000) · Synapse · doi:10.1002/1098-2396(20001201)38:3<305::aid-syn9>3.0.co;2-u · Cited by 38
Lerma, J. (1999) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-08022-1_8 · Cited by 12
A pharmacological profile of the high-affinity GluK5 kainate receptor
Møllerud, S., Kastrup, J. S., & Pickering, D. S. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.049 · Cited by 11
“Relatively selective GluK1 agonists (e.g. (RS)-2-amino-3-(5-tert-butyl3-hydroxyisoxazol-4-yl)propionate [ATPA]) (Clarke et al., 1997; Lauridsen et al., 1985) and antagonists (e.g. (S)-1-(2-amino-2-carboxyethyl)-3-(2-carboxy-thiophene-3-yl-methyl)-5-methylpyrimidine-2,4-dione [UBP310]) (Dolman et…”
Valgeirsson, J., Christensen, J. K., Kristensen, A. S., Pickering, D. S., Nielsen, B., Fischer, C. H., Bräuner‐Osborne, H., Nielsen, E. Ø., Krogsgaard‐Larsen, P., & Madsen, U. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00485-1 · Cited by 11
Frølund, B., Greenwood, J., Holm, M., Egebjerg, J., Madsen, U., Nielsen, B., Bräuner-Osborne, H., Stensbøl, T. B., & Krogsgaard-Larsen, P. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.06.024 · Cited by 9
Hilton, G. D., Ndubuizu, A. N., Nuñez, J. L., & McCarthy, M. M. (2005) · Developmental Brain Research · doi:10.1016/j.devbrainres.2005.07.007 · Cited by 11
Salmen, B., Beed, P. S., ÖZDOĞAN, T., Maier, N., Johenning, F. W., Winterer, J., Breustedt, J., & Schmitz, D. (2010) · Hippocampus · doi:10.1002/hipo.20846 · Cited by 17
“We therefore applied the GluK1 specific agonist (S)-2-amino-3-(5tert-butyl-3-hydroxy-4-isothiazolyl)propionic acid (ATPA) (Ornstein et al., 1996, Clarke et al., 1997; Clarke and Collingridge, 2002; Clarke and Collingridge, 2004) to investigate the influence of this receptor in AMPAR mediated…”
MethodBaldwin, J. E., Fryer, A. M., & Pritchard, G. J. (2001) · The Journal of Organic Chemistry · doi:10.1021/jo000847d · Cited by 10
Zinc Modulates Olfactory Bulb Kainate Receptors
Blakemore, L. J., & Trombley, P. Q. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.11.041 · Cited by 12
“The (mostly) inhibitory effects of kainate and ATPA on IPSCs could be due to activation of presynaptic KARs on mitral and tufted cells, reducing glutamate release, and/or the activation of postsynaptic KARs on PG cells and granule cells, reducing GABA release.”
BackgroundMethodInfluentialLee, H. S., Chong, W., Han, S. K., Lee, M. H., & Ryu, P. D. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00490-5 · Cited by 10
Pajouhesh, H., Meresht, M. H., Pajouhesh, S. H., & Curry, K. (2000) · Tetrahedron Asymmetry · doi:10.1016/s0957-4166(00)00484-5 · Cited by 9
Selective Targeting of Glutamate Receptors in Neurons
Rubio, M. E. (2000) · Molecular Neurobiology · doi:10.1385/mn:21:1-2:001 · Cited by 11
Plasma membrane remodeling in GM2 gangliosidoses drives synaptic dysfunction
Nicholson, A. S., Priestman, D. A., Antrobus, R., Williamson, J. C., Bush, R., McKie, S. J., Barrow, H. G., Smith, E., Dobrenis, K., Bright, N. A., et al. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003265 · Cited by 12
“Additional evidence of changes at the PM that are driven by altered GM2 metabolism and that may influence synaptic signalling in these neurons is the increased abundance of KCNA2, SCN2b and GRIK1 which are voltage and neurotransmitter gated potassium and sodium channels [71–73].”
Wu, D., Zhou, N., & Yu, L. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03762-9 · Cited by 8
Kainate Receptors Play a Role in Modulating Synaptic Transmission in the Olfactory Bulb
Blakemore, L. J., Corthell, J. T., & Trombley, P. Q. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.09.002 · Cited by 9
“Some currents may reflect activation of GluK1-containing KARs—GluK1containing receptors mediate kainate-activated currents in DRG neurons (Partin et al., 1993; Clarke et al., 1997).”
BackgroundInfluentialOhkubo, J., Ohbuchi, T., Yoshimura, M., Maruyama, T., Ishikura, T., Matsuura, T., Suzuki, H., & Ueta, Y. (2014) · Journal of Neuroendocrinology · doi:10.1111/jne.12128 · Cited by 8
Contractor, A., & Swanson, G. T. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-055-3_3 · Cited by 10
Зинченко, В. П., Gaidin, S. G., Teplov, I. Y., & Kosenkov, A. M. (2017) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747817040110 · Cited by 9
Excitotoxic injury profiles of low-affinity kainate receptor agonists in cortical neuronal cultures
Moldrich, R. X., Cheung, N. S., Pascoe, C. J., & Beart, P. M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00456-2 · Cited by 8
Chapter 2 Gluk1 Receptor Antagonists and Hippocampal Mossy Fiber Function
Nisticò, R., Amici-Dargan, S., Fitzjohn, S. M., Lodge, D., Jane, D. E., Collingridge, G. L., & Bortolotto, Z. A. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)85002-2 · Cited by 8
Self-citationCherubini, E., Caiati, M. D., & Sivakumaran, S. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9557-5_2 · Cited by 8
Lesion of substantia nigra pars compacta by the GluR5 agonist ATPA
Vivó, M., Camón, L., de Vera, N., & Martı́nez, E. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03373-5 · Cited by 7
Pharmacology of AMPA/kainate receptors
Madsen, U., Johansen, T. N., Stensbøl, T. B., & Krogsgaard‐Larsen, P. (2001) · Pharmaceutical science series · doi:10.1201/9780203299388.ch5 · Cited by 9
Pharmacological profile of the isomers of the GluR-specific agonist ATPA
Curry, K., & Pajouhesh, H. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-76-6-690 · Cited by 7
Kainate receptors and RNA editing in cholinergic neurons
Olsen, D. P., Dunlap, K., & Jacob, M. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04359.x · Cited by 7
“In addition, we tested the GluR5 selective agonist ATPA at 1 lmol/L (Clarke et al. 1997; Hoo et al. 1999), a concentration approximately 2.5-fold higher than its EC50 at recombinant GluR5-containing KARs (Alt et al. 2004) and >30-fold lower than its EC50 at AMPA receptors (Matzen et al. 1997).”
MethodInfluentialBunch, L., Pickering, D. S., Gefflaut, T., Vinatier, V., Hélaine, V., Amir, A., Nielsen, B., & Jensen, A. A. (2009) · ChemMedChem · doi:10.1002/cmdc.200900258 · Cited by 7
The Role of -Containing Kainate Receptors in Entorhinal Cortex Gamma Frequency Oscillations
Stanger, H. L., Alford, R., Jane, D. E., & Cunningham, M. O. (2008) · Neural Plasticity · doi:10.1155/2008/401645 · Cited by 8
“It was not surprising then that application of the GLUK5 subunit selective agonist ATPA [41] successfully evoked gamma frequency oscillations in the MEC.”
BackgroundLigands for kainate subtype glutamate receptors
Shou, X., & Chamberlin, A. R. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.4.471 · Cited by 6
“In addition, iGluR7 mRNA was found in the deep layers of the cerebral cortex, KA1 exclusively in the CA3 region and KA2 in essentially every part of the nervous system [37-40].”
BackgroundFrydenvang, K., Greenwood, J. R., Vogensen, S. B., & Brehm, L. (2002) · Structural Chemistry · doi:10.1023/a:1020569622239 · Cited by 6
Ionotropic Glutamate Receptors
Bleakman, D., Alt, A. J., Lodge, D., Monaghan, D. T., Jane, D. E., & Nisenbaum, E. S. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn010 · Cited by 6
Self-citationGlutamate Receptors and Synaptic Plasticity in Health and Disease: A Personal Journey
Collingridge, G. L. (2026) · Hippocampus · doi:10.1002/hipo.70062 · Cited by 8
“Next, in collaboration with David Lodge at Eli Lilly, Vernon Clarke identified a role of kainate receptors regulating GABAergic inhibition (Clarke et al. 1997).”
Self-citationRuiz, A. J. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-9557-5_6 · Cited by 6
O‘Neill, M. F., Sanger, G. J., Ornstein, P. L., Osborne, D. J., & Woodhouse, S. M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2055-8 · Cited by 5
Self-citationPharmacology of Glutamate Receptors
Witkin, J. M., Kaminski, R. M., & Rogawski, M. A. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-306-4_2 · Cited by 5
GABA and Glutamate Receptor Ligands and their Therapeutic Potential in CNS Disorders
Madsen, U., Bräuner‐Osborne, H., Greenwood, J. R., Johansen, T. N., Krogsgaard‐Larsen, P., Liljefors, T., Nielsen, M., & Frølund, B. (2010) · Wiley eBooks · doi:10.1002/9780470571224.pse019 · Cited by 5
α2δ-2 regulates synaptic GluK1 kainate receptors in Purkinje cells and motor coordination
Zhou, M., Zhou, J., Chen, S.-R., Chen, H., Jin, D., Huang, Y., Shao, J.-Y., & Pan, H. (2024) · Brain · doi:10.1093/brain/awae333 · Cited by 6
Kainate Receptor-Induced Retrograde Inhibition of Glutamatergic Transmission in Vasopressin Neurons
Bonfardin, V. D. J., Theodosis, D. T., Konnerth, A., & Oliet, S. H. R. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3017-11.2012 · Cited by 4
“To this end, we used the GluK1-containing KAR selective agonist ATPA (Clarke et al., 1997; Bortolotto et al., 1999).”
Jane, D. E. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60374-5 · Cited by 6
Зинченко, В. П., Gaidin, S. G., Teplov, I. Y., Kosenkov, A. M., Sergeev, A. I., Долгачева, Л. П., & Tuleuhanov, S. T. (2020) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747820010109 · Cited by 5
“ATPA was used as a selective CP-KAR agonist [35].”
Zhu, X., Jin, S., Ng, Y. K., Lee, W. L., & Wong, P. T. ‐. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03159-6 · Cited by 4
Heger, S., & Ojeda, S. R. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-499-5_1 · Cited by 4
AMPA receptors jump the synaptic cleft
Nicoll, R. A., Frerking, M. E., & Schmitz, D. (2000) · Nature Neuroscience · doi:10.1038/75689 · Cited by 4
Excitotoxic profile of LY339434, a GluR5 agonist, in cultured murine cortical neurons
Moldrich, R. X., Cheung, N. S., Pascoe, C. J., Baker, S., Pedregal, C., & Beart, P. M. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02122-3 · Cited by 4
Dimpfel, W., & Biller, A. (2015) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2015.59036 · Cited by 3
Crowder, T. L., Ariwodola, O. J., & Weiner, J. L. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.133 · Cited by 6
Gender‐dependent ATPA‐induced changes in long‐term potentiation in the rat lateral amygdala
Schubert, M., Drephal, C., & Albrecht, D. (2007) · The FASEB Journal · doi:10.1096/fj.07-9415com · Cited by 3
“At this concentration, the agonist acts only on GLUK5-containing kainate receptors (23).”
BackgroundResultNeuroendocrine Regulation of Puberty
Terasawa, E., & Ojeda, S. R. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00064-4 · Cited by 7
Dai, W., Ebert, B., Madsen, U., & Lambert, J. D. C. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702236 · Cited by 3
Medicinal Chemistry of α‐Amino Acids
Bunch, L., & Krogsgaard‐Larsen, P. (2011) · doi:10.1002/9783527631827.ch4 · Cited by 3
Plasma Membrane Remodelling in GM2 Gangliosidoses Drives Synaptic DysfunctionPreprint
Nicholson, A. S., Priestman, D. A., Antrobus, R., Williamson, J. C., Bush, R., Barrow, H. G., Smith, E., Dobrenis, K., Bright, N. A., Platt, F. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.20.608810 · Cited by 3
“Additional evidence of changes at the PM that are driven by altered GM2 metabolism and that may influence synaptic signalling in these neurons is the increased abundance of KCNA2, SCN2b and GRIK1 which are voltage and neurotransmitter gated potassium and sodium channels [69–71].”
BackgroundJane, D. E. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60375-7 · Cited by 3
Kallman, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_28 · Cited by 2
Inhibition of high K+-evoked γ-aminobutyric acid release by sodium nitroprusside in rat hippocampus
Hada, J., Kaku, T., Jiang, M. H., Morimoto, K., & Hayashi, Y. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01605-4 · Cited by 2
Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications
(2000) · Pharmacochemistry library · doi:10.1016/s0165-7208(00)80022-7 · Cited by 2
Alger, B. E. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4739-6_7 · Cited by 2
Delineation of the Physiological Role of Kainate Receptors by Use of Subtype Selective Ligands
Lauri, S. E., Clarke, V. R. J., & Collingridge, G. L. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-672-0_2 · Cited by 2
“Both have been used to study the physiological functions of kainate receptors in the presence of AMPA receptor selective antagonists (31,34,35).”
BackgroundMethodInfluentialSelf-citationNeuropathic pain mechanisms and potential future pharmacotherapeutic strategies
Smith, H. S. (1998) · Current Review of Pain · doi:10.1007/s11916-998-0023-4 · Cited by 2
Transgenic models for glutamate receptor function
Doherty, A., & Collingridge, G. (2001) · CRC Press eBooks · doi:10.1201/9780203299388-23 · Cited by 2
Transgenic models for glutamate receptor function
Doherty, A., & Collingridge, G. L. (2001) · Pharmaceutical science series · doi:10.1201/9780203299388.pt6 · Cited by 2
Self-citationThe Role of GABA and Its Receptors in Temporal Lobe Epilepsy
Sperk, G., & Pirker, S. (2026) · Biomolecules · doi:10.3390/biom16030422 · Cited by 5
Crépel, V. (2013) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.80 · Cited by 1
Lee, J. H., Lee, E. J., Jang, Y. Y., Jeong, J. E., Chung, H. L., & Kim, W. T. (2016) · Perinatology · doi:10.14734/pn.2016.27.3.149 · Cited by 1
Hogner, A., Kastrup, J. S., Greenwood, J. R., Vogensen, S. B., Møller, E. H., Stensbøl, T. B., Egebjerg, J., & Krogsgaard‐Larsen, P. (2002) · Pharmacochemistry library · doi:10.1016/s0165-7208(02)80002-2 · Cited by 1
Chapter 5.9 Modelling Down syndrome in mice
Dierssen, M., Pritchard, M. A., Fillat, C., Arbonés, M. L., Aran, J. M., Flórez, J., & Estivill, X. (1999) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(99)80066-2 · Cited by 2
Jin, S., Yang, J. T., Lee, W. L., & Wong, P. T. ‐. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02857-2 · Cited by 1
Pharmacology and electrophysiology of excitatory amino acid receptors
Priestley, T. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8139-5_2 · Cited by 2
Synaptic modifications in hippocampal CA3 pyramidal cells in an Alzheimer's mouse model
Zhang, P. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6752 · Cited by 1
Bancila, V. (2004) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:291
Segerstråle, M. (2011) · Helda - University of Helsinki Institutional Repository
Synaptic Targeting of Neurotransmitter Receptors is Regulated by Neurobeachin
Nair, R. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-511
Modulation of hippocampal gamma oscillations by dopamine and serotonin receptor subtypes
Johnston, A. D. (2014) · Figshare
Különböző neuroprotekciós lehetőségek tanulmányozása ischaemiás patkány modelleken
Nagy, D. (2011) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.645
Doble, A. (1999) · Douleur et Analgésie · doi:10.1007/bf03008484 · Cited by 1
Neurophysiological mechanisms of inhibition and disinhibition in processing of cognitive information
Shul’gina, G. I., Kositzyn, N. S., & Svinov, M. M. (2011) · Doklady Biological Sciences · doi:10.1134/s001249661105022x
Krüger, H. (2000) · doi:10.18452/14462
“…es nach Aktivierung dieses Rezeptors an der präsynaptischen Membran von inhibitorischen GABAergen Synapsen zur verminderten GABA Freisetzung kommt (Clarke et al. 1997), während seine Aktivierung an der postsynaptischen Membran von CA3 Pyramidenzellen eine exzitatorische postsynaptische Antwort…”
BackgroundJin, S., Yang, J. T., & Lee, W. L. (2000)
KainateReceptor-InducedRetrogradeInhibitionof GlutamatergicTransmissioninVasopressinNeurons
Bonfardin, J., & Oliet, R. (2012)
Development of microfluidic applications to study the role of kainate receptors in synaptogenesis
Sakha, P. (2016) · Helda - University of Helsinki Institutional Repository
Role of the Anterior Cingulate Cortex in Fear Learning and Sensation Related Behaviors
Descalzi, G. (2014) · TSpace (University of Toronto)
Monaghan, D. T., More, J. C. A., Feng, B., & Jane, D. E. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_4
Зинченко, В. П., Gaidin, S. G., Teplov, I. Y., & Kosenkov, A. M. (2017) · Биологические мембраны Журнал мембранной и клеточной биологии · doi:10.7868/s0233475517040041
Metadata
- Authors
- Clarke, V. R. J., Ballyk, B. A., Hoo, K. H., Mandelzys, A., Pellizzari, A., Bath, C. P., Thomas, J., Sharpe, E. F., Davies, C. H., Ornstein, P. L., Schoepp, D. D., Kamboj, R. K., Collingridge, G. L., Lodge, D., & Bleakman, D.
- Affiliations
- University of Bristol (GB)
- Eli Lilly (United Kingdom) (GB)
- University of Edinburgh (GB)
- Eli Lilly (United States) (US)
- Venue
- Nature
- Published
- 1997-10
- Volume
- 389
- Issue
- 6651
- Pages
- 599-603
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1637705010
- Cited by
- 416
- References
- 32
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 7 · 2016: 7 · 2015: 4 · 2014: 7 · 2013: 5 · 2012: 11
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Wellcome Trust
- Chinese Academy of Agricultural Sciences
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- GluR5, kainate receptors, hippocampus, synaptic inhibition, atpA, glutamate receptors, epilepsy
- MeSH terms
- Animals, Cell Line, Cloning, Molecular, Hippocampus, Humans, Isoquinolines, Isoxazoles, Kainic Acid, Neural Inhibition, Propionates, Receptors, GABA-A, Synapses, Tetrazoles, Kainic Acid Receptors, Excitatory Amino Acid Agonists, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.